Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MBX

MBX Biosciences Inc

May 29 • 04:00PM ET

31.47

-0.43 -1.35 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL BMRN RYTM INCY KRYS VKTX AXSM MDGL NBIX

| Held by: VTI IWM VXF IWN XPH IBB VTWO SCHA IWC FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.21	Insider Own	38.13%	Shs Outstand	47.57M	Perf Week	-1.01%
Market Cap	1.50B	Forward P/E	-	EPS next Y	-3.91	Insider Trans	-0.29%	Shs Float	29.45M	Perf Month	10.00%
Enterprise Value	1.06B	PEG	-	EPS next Q	-0.64	Inst Own	75.62%	Short Float	14.55%	Perf Quarter	-3.32%
Income	-86.61M	P/S	-	EPS this Y	-17.75%	Inst Trans	11.46%	Short Ratio	7.55	Perf Half Y	-0.41%
Sales	0.00M	P/B	3.42	EPS next Y	-39.37%	ROA	-24.79%	Short Interest	4.28M	Perf YTD	-0.22%
Book/sh	9.20	P/C	3.40	EPS next 5Y	-20.53%	ROE	-25.73%	52W High	45.85 -31.36%	Perf Year	147.41%
Cash/sh	9.24	P/FCF	-	EPS past 3/5Y	-44.91% -	ROIC	-19.77%	52W Low	9.43 233.72%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.22% 8.23%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-0.43%	Oper. Margin	-	ATR (14)	2.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	30.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.12	Recom	1.42
Dividend Gr. 3/5Y	- -	Current Ratio	30.79	EPS Q/Q	29.35%	SMA20	-4.99%	Beta	0.77	Target Price	69.09
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-1.14%	Rel Volume	1.45	Prev Close	31.90
Employees	63	LT Debt/Eq	0.00	Earnings	May 07 BMO	SMA200	15.83%	Avg Volume	567.33K	Price	31.47
IPO	Sep 13, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.78% -	Trades		Volume	821,229	Change	-1.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)